The Anti-Diabetes Drugs market in Republic of the Congo has been showing a steady growth in recent years.
Customer preferences: The customers in Republic of the Congo prefer oral anti-diabetic drugs over injectables. This is mainly due to the convenience of oral drugs and the fear of needles among the population. The customers also prefer drugs with minimal side effects and those that are affordable.
Trends in the market: The Anti-Diabetes Drugs market in Republic of the Congo is witnessing a shift towards generic drugs. This is due to the government's efforts to reduce healthcare costs by promoting the use of generic drugs. The market is also seeing an increase in the demand for combination therapies, which offer better glycemic control and reduce the risk of hypoglycemia.
Local special circumstances: Republic of the Congo has a high prevalence of diabetes, which is mainly attributed to the adoption of a westernized lifestyle and diet. The healthcare system in the country is underdeveloped, and there is a shortage of healthcare professionals. This has resulted in low awareness of diabetes and its complications among the population.
Underlying macroeconomic factors: The economy of Republic of the Congo is heavily dependent on oil exports, which have been volatile in recent years. The government has been implementing austerity measures to reduce the budget deficit, which has resulted in reduced healthcare spending. The high cost of importing drugs has also been a challenge for the market. However, the government has been taking steps to promote local production of drugs, which is expected to reduce the cost of drugs in the long run.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
